Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

203
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
203
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

259
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
259
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

281
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
281
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

233
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
233
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

352
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
352
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

175
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
175

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor Microenvironment Hijacks and Accelerates a Physiological Myeloid Senescence Signature Associated with Pan-Cancer Immunosuppression and Prognostic Stratification.

International journal of molecular sciences·2026
Same author

Comparison of liver T1 estimates generated by breath-hold 3D FSPGR and free-breathing 3D radial stack-of-stars FSPGR variable flip angle T1 mapping sequences.

European journal of radiology open·2026
Same author

Fiber-Optic Quantum Dots Sensor for Dynamic and Quantitative Thermal Monitoring of Spheroids toward Single-Cellular Resolution.

ACS nano·2026
Same author

Celastrol Suppresses Porcine Deltacoronavirus Replication by Modulating Endoplasmic Reticulum Stress-Associated Ca<sup>2+</sup> Balance.

Transboundary and emerging diseases·2026
Same author

Notoginsenoside R1 Inhibits Porcine Deltacoronavirus Infection In Vitro by Restoring SERCA2-Mediated Calcium Homeostasis.

Animals : an open access journal from MDPI·2026
Same author

Mind the Gap: A Sequential 4-Step Missing Data Management for CGM-Derived Endpoints in Diabetes Clinical Trials.

Journal of diabetes science and technology·2026

Related Experiment Video

Updated: Aug 28, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Retrieved-Dropout-Based multiple imputation for time-to-event data in cardiovascular outcome trials.

Jiwei He1, Roberto Crackel1, William Koh1

  • 1Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Journal of Biopharmaceutical Statistics
|September 19, 2022
PubMed
Summary

This study extends retrieved-dropout multiple imputation for continuous outcomes to time-to-event endpoints. The method effectively handles missing data in clinical trials, offering an alternative to traditional survival analysis techniques.

Keywords:
Missing datacardiovascular outcome trialmultiple imputationretrieved dropouttreatment policy estimand

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

201
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Last Updated: Aug 28, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

201
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Survival Analysis

Background:

  • Multiple imputation is crucial for handling missing data in clinical trials.
  • Retrieved-dropout multiple imputation has been applied to continuous endpoints for treatment policy estimands.
  • Extending this method to time-to-event data is a significant methodological advancement.

Purpose of the Study:

  • To extend retrieved-dropout-based multiple imputation to time-to-event endpoints.
  • To provide a practical implementation guide for this advanced statistical method.
  • To compare the performance of this method against established techniques like Cox proportional hazards models.

Main Methods:

  • Application of retrieved-dropout multiple imputation to time-to-event data.
  • Utilizing data from study completers and dropouts within the same treatment arm.
  • Comparison with Cox proportional hazard and reference-based multiple imputation using a cardiovascular outcome trial dataset.

Main Results:

  • The extended retrieved-dropout multiple imputation method is feasible for time-to-event endpoints.
  • Demonstration of practical implementation using real-world clinical trial data.
  • Comparative analysis highlights the utility and potential advantages over existing methods.

Conclusions:

  • Retrieved-dropout multiple imputation offers a viable approach for analyzing time-to-event data with treatment discontinuation.
  • This methodology enhances the ability to address the treatment policy estimand in survival analysis.
  • The study provides valuable insights for statisticians and researchers in clinical trial design and analysis.